💨 Abstract

The Trump administration has canceled $766 million in funding awarded to Moderna for developing a potential H5N1 bird flu vaccine. The decision came despite promising early trial results and concerns about the virus's potential to cause a pandemic. Health Secretary Robert F. Kennedy Jr.'s skepticism regarding mRNA vaccines is believed to have influenced the withdrawal of funds. The canceled funding aimed to support advanced trials for the vaccine.

Courtesy: WTOP Staff